US2008255176A1PendingUtilityA1
Quinoline derivatives
Est. expiryMar 7, 2022(expired)· nominal 20-yr term from priority
A61P 27/02A61P 27/06A61P 27/00A61P 27/10C07D 401/06C07D 513/04
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to novel benzo[g]quinoline derivatives, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A compound, in free base or acid addition salt form, according to formula I
3 - 4 . (canceled)
5 . A method for the treatment of glaucoma and myopia in a subject in need of such treatment, which comprises administering to such subject a therapeutically effective amount of a compound according to claim 2 in free base or pharmaceutically acceptable acid addition salt form.
6 . A pharmaceutical composition comprising a compound of claim 2 and at least one pharmaceutically acceptable diluent or carrier.Join the waitlist — get patent alerts
Track US2008255176A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.